2025年3月18日周二，Schrodinger Inc（NASDAQ: SDGR）在2025年KeyBanc年度医疗保健论坛上进行了演讲。在首席执行官Rami Fareed的带领下，讨论重点围绕公司创新的计算机辅助药物研发平台，强调了其进展和挑战。尽管公司去年的财务表现超出预期，但在平衡内部和合作项目方面仍面临持续性任务。

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Learn how AI-driven TechBio is revolutionizing biotech in our exclusive interview with Bullfrog AI CEO Vin Singh.

Schrödinger, Inc. (Nasdaq: SDGR) today reported that on March 15, 2025, the company granted (i) a non-statutory stock option to purchase 1,575 shares of the company’s common stock to one newly hired ...

Emma’s gone”, I texted one of my closest friends. To the shops? To another country? To another man? I clarified after he ...

Adding metformin to letrozole and abemaciclib (Verzenio) was tied to deep responses and prolonged progression-free survival ...

Explore how America, despite its claims of promoting free speech, systematically undermines it through selective censorship and suppression of dissent throughout its history.

With another season of Invincible coming to an end, fans of Amazon’s adult animation correctly guessed that the long-awaited ...

Counter-Strike 2's skin market hits $4.27B while Ubisoft's NFT experiment crashed and burned. What made one succeed where the ...

After hours: March 18 at 4:05:11 PM EDT Loading Chart for CSBR ...

After hours: March 17 at 6:55:56 PM EDT Loading Chart for FLGT ...